AGTC to Present at Upcoming Conferences

UF startup Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that management will be participating in the following conferences:

• 14th Annual Wells Fargo Securities Healthcare Conference – Boston (September 4-5, 2019)
• 21st Annual H.C. Wainwright Global Investment Conference – New York (September 9-10, 2019)
• Janney Montgomery Scott Healthcare Conference 2019 – New York (September 9-10, 2019)

A live audio webcast of the presentation at the Wells Fargo and H.C. Wainwright conferences can be accessed by visiting https://ir.agtc.com/events-and-presentations. A replay will be available on the company’s website following the event.

Learn more about AGTC to Present at Upcoming Conferences.